Clifford Goodman, PhD, is a Senior Vice President at The Lewin Group, a health care policy consulting firm based in Falls Church, Virginia.  Dr. Goodman has more than 30 years of experience in such areas as health technology assessment, comparative effectiveness research, clinical practice guidelines, and studies pertaining to health care innovation, regulation, and payment.  He directs studies and projects for an international range of government agencies; pharmaceutical, biotechnology, and medical device companies; health care provider institutions; and professional, industry, and patient advocacy groups.  His recent work has involved such areas as oncology, various chronic conditions, infectious disease, blood disorders, organ donation and transplantation, diagnostic testing, pharmacogenomics, gene therapy, value frameworks, value-based contracting, and biosimilars.  Dr. Goodman is an internationally recognized health policy issues moderator and facilitator of expert panels, health industry advisory boards, workshops, and focus groups.  He served as Chair of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC, 2009-12) for the US Centers for Medicare and Medicaid Services.  He served as President of the professional society, Health Technology Assessment International (HTAi, 2011-13), and is a Fellow of the American Institute for Medical and Biological Engineering.  He received a PhD from The Wharton School of the University of Pennsylvania, a Master of Science from The Georgia Institute of Technology, and a Bachelor of Arts from Cornell University.  The Lewin Group is an Optum company, a wholly owned subsidiary of UnitedHealth Group.